Definitive Contract 75D30121C10094
Award Date 12/18/20
Potential Completion Date 11/29/22
Potential Value $3.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Nashville, TN 37232, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
25
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a prime contract award from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC), a leading academic medical center and nonprofit healthcare provider. The $33,581,705.97 fixed-price contract, awarded under the CDC's Fiscal Year 2021 Broad Agency Announcement, supports VUMC's research on topics related to Topic 9.1. The contract has no set-aside designation. VUMC is a major recipient of federal funding and has extensive experience managing...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price Definitive Contract to Vanderbilt University Medical Center (VUMC), a nonprofit healthcare provider, for $1,347,111.90. The contract, titled "FY 21 BAA TOPIC 9 - VUMC," has a completion date of September 30, 2022. VUMC, which does business as Vumc, is a major academic medical center that provides a wide range of healthcare services and conducts extensive...
- This is a $4,462,978.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) for monitoring and coordinating personal protective equipment (PPE). The contract does not have a set-aside designation. VUMC is a major academic medical center and nonprofit healthcare provider based in Nashville, Tennessee, with extensive experience managing multi-year, multi-million dollar federal awards, including from the National...
- Vanderbilt University Medical Center was awarded a definitive cost-plus-fixed-fee contract valued at $14,222,774.34 by the Centers for Disease Control and Prevention under funding opportunity announcement topic 9.3. The prime contractor will lead a network of subcontractors to conduct a prospective cohort study to assess the effectiveness of COVID-19 and influenza vaccines in preventing virus transmission within households. Major subcontractors include the Universities of Arizona, Emory,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,995,944 definitive cost-no-fee contract to Vanderbilt University Medical Center for Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2. Vanderbilt University Medical Center will serve as the prime contractor and has subcontracted portions of the work to 26 other institutions, including The Cleveland Clinic Foundation, University of Utah, Beth Israel Deaconess...
- This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Vanderbilt University Medical Center (VUMC) on August 26, 2019. The contract, valued at $783,571.11, is for services related to "DOMAIN 1-A003 OPIOID - STATES W/ OUTBREAKS OF HEPATITIS B" and has a completion date of February 25, 2021. The contract is a task order under the larger Safety and Healthcare Epidemiology Prevention Research...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $4.8 million definitive contract to Vanderbilt University Medical Center to conduct research titled "Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Disease in Adults." The prime contractor will lead a network of 16 academic medical centers as subcontractors to study the effectiveness of influenza vaccines in preventing critical illness. This award was...
- This is a federal contract award to The Vanderbilt University, a private research university, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for CLINICAL EVALUATION LEAD SITE services. The $4,879,802.00 contract is a Delivery Order under the larger Clinical Immunization Safety Assessment (CISA) contract vehicle. The award does not have a set-aside designation. As the prime contractor, Vanderbilt University will provide critical research and...
- This is a cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university, to provide COVID-19 response efforts. The $1,835,654.79 contract has a performance period running from July 1, 2020 through June 30, 2023. As part of this contract, Vanderbilt University Medical Center (VUMC) is serving as a subcontractor to provide molecular testing and epidemiology support, including day-to-day supervision...